Search results (166)
« Back to NewsNew study confirms malaria drug is safe for children and could reduce disease spread
25 April 2025
A major study in The Lancet Infectious Diseases confirms that single low-dose primaquine is safe and effective in reducing malaria transmission in young children. Analysing data from over 6,000 patients, researchers found it effective even in young children and areas with high malaria burden. The findings support expanding primaquine use to tackle drug-resistant malaria in Africa. A child-friendly formulation is urgently needed to maximise its impact on malaria elimination efforts worldwide.
Study shows urgent change needed to reduce deaths from malaria and meningitis in comatose African children
22 April 2025
Results of two parallel studies show that one in four African children hospitalised with malaria and coma have an additional infection, and that giving antibiotics with antimalarials could help reduce death rates of comatose children.
Nearly 500,000 children could die from AIDS-related causes by 2030 without stable PEPFAR programmes, Oxford experts estimate
14 April 2025
Oxford experts estimate that 1 million additional children could become infected with HIV and nearly 500,000 children could die from AIDS by 2030, while as many as 2.8 million children could become orphaned in the next five years if US President’s Emergency Plan for AIDS Relief (PEPFAR) programmes are reduced or eliminated.
Addressing healthcare workforce challenges with new research partnership
9 April 2025
Researchers from the Nuffield Department of Primary Care Health Sciences are part of a major new research initiative aimed at tackling critical workforce challenges in healthcare, particularly in underserved communities.
KEMRI signs landmark partnership with Wellcome and Oxford
3 April 2025
The Kenya Medical Research Institute (KEMRI) has officially entered into a seven-year Memorandum of Understanding (MoU) with Wellcome, a UK-based charitable foundation, and the University of Oxford. The £91 million agreement was signed at the Wellcome headquarters in London, marking a significant boost for medical research and training in Kenya.
Prioritising research to better address high-consequence outbreaks
19 March 2025
A new paper published in BMC Medicine analyses research prioritisation approaches for high-consequence pathogens.
60% of hepatitis C patients do not know how they had the disease
5 March 2025
A survey at Vietnam's National Hospital for Tropical Diseases found 60% of hepatitis C patients unaware of how they contracted the disease, often diagnosed late. Globally, viral hepatitis causes 3,500 daily deaths, ranking second among infectious killers after tuberculosis.
Study finds previously unidentified genetic determinants of rare disease
28 February 2025
A landmark study involving researchers from NDM’s Centre for Human Genetics has identified 69 previously unidentified genetic determinants of rare disease, including uncommon forms of epilepsy and schizophrenia.
Study provides support for WHO guidelines for treating pregnant women with HIV
26 February 2025
A new analysis by researchers at Oxford Population Health’s Infectious Disease Epidemiology Unit has provided robust evidence in support of current World Health Organization (WHO) guidelines for treating pregnant women living with HIV. The study is published in Clinical Microbiology and Infection.
IOI awards £5m to Oxford consortium to develop new therapies for drug-resistant tuberculosis
25 February 2025
The Ineos Oxford Institute for antimicrobial research (IOI) has awarded £5 million to a group of 17 interdisciplinary researchers from Oxford University to develop new therapies for drug-resistant tuberculosis.
Bangladesh malaria mass vaccine and drug administration trial begins
19 February 2025
After more than a year of community engagement and preparation in 100 villages with 12,000 populations across the Chittagong Hill Tracts, the mass malaria vaccine (R21/Matrix M) and drug (DHA, piperaquine, and single low dose primaquine) administration study started on 15 Feb.
Advances in AI can help prepare the world for the next pandemic
19 February 2025
In the first study of this kind, PSI and Oxford researchers partner with global colleagues to outline how Artificial Intelligence can transform infectious disease research and save more lives.
Researchers develop AI-powered tools to improve pneumonia care
19 February 2025
A team of researchers at OUCRU was recently awarded a multi-million-dollar Discovery Award from the Wellcome Trust to develop AI tools to advance pneumonia research.
New partnership to advance public health and life science research collaboration in West Africa
13 February 2025
PSI and Institut Pasteur de Dakar (IPD) will cooperate on developing vaccines and rapid diagnostics – as well as strengthening workforce in the vaccinology, clinical trials and biomanufacturing sectors.
Oxford Martin School epilepsy programme launches innovative research centre
3 February 2025
International, national and local partners have been welcomed to the launch of the world’s first centre dedicated to empowering global epilepsy research and care.
Identifying fake COVID-19 vaccines by analysing vial labels and vaccine liquids
31 January 2025
Researchers in the Nuffield Department of Medicine and their collaborators, including the Serum Institute of India, have published an innovative method to identify falsified vaccines without opening the vaccine vial. The new method analyses the vaccine vial label and its adhesive and therefore allows genuine vaccine vials to be retained in the supply chain. This technique can also differentiate genuine Covid-19 vaccine liquid from falsified vaccine surrogates.
Blog: Research priorities for a warming world
30 January 2025
Professor Deirdre Hollingsworth, Professor of Infectious Disease Epidemiology at NDM’s Centre for Tropical Medicine and Global Health and the Big Data Institute, looks at potential ways to advance research on the impact of climate change on malaria and neglected tropical diseases (NTDs).
RECOVERY trial finds that sotrovimab reduces the risk of death in some patients hospitalised with COVID-19
27 January 2025
The Randomised Evaluation of COVID-19 Therapy (RECOVERY) trial has found that sotrovimab reduced the risk of death in patients hospitalised with COVID-19, but only in those with higher levels of the virus present in their blood. The results have been published on medRxiv and will be submitted to a peer-reviewed medical journal.
Our Future Health database open to researchers
21 January 2025
Our Future Health’s database is open to researchers who conduct health research for the public good.
Inhaled vaccines could reduce viral transmission
9 January 2025
An important step toward advancing vaccines for human use, a recent study has shown that inhaled vaccines could potentially improve efficiency and reduce viral transmission.